Laguna Niguel, CA, United States of America

Igor Valyunin

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 207(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Igor Valyunin: Innovator in Ophthalmic Technology

Introduction

Igor Valyunin is a notable inventor based in Laguna Niguel, CA (US). He has made significant contributions to the field of ophthalmic devices, holding a total of 4 patents. His work focuses on improving vision correction technologies, particularly through innovative lens designs.

Latest Patents

One of Valyunin's latest patents is for an accommodative intraocular lens. This lens provides multiple focuses due to a bi-directional shift along the eye's optical axis, while also minimizing or preventing posterior chamber opacification. The design includes a first component consisting of an optical body and a haptic body, and a second component that maintains substantial contact with the posterior surface of the capsular bag when implanted. Additionally, he has developed crystalline polymeric compositions for ophthalmic devices. These devices are suitable for implantation through small incisions and are made from materials with specific thermal properties, including intraocular lenses and ocular drug delivery devices.

Career Highlights

Throughout his career, Igor Valyunin has worked with various companies, including Medennium, Inc. His innovative approaches have led to advancements in the design and functionality of ophthalmic devices, enhancing patient outcomes.

Collaborations

Valyunin has collaborated with notable professionals in the field, including Stephen Q Zhou and Christopher D Wilcox. These partnerships have contributed to the development of cutting-edge technologies in ophthalmology.

Conclusion

Igor Valyunin's contributions to ophthalmic technology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence advancements in vision correction and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…